Osisko Development Announces Further Upsize of Previously Announced "Bought Deal" Offering
Osisko Development (NYSE: ODV) further upsized its previously announced bought‑deal financing to a total C$75 million offering on Oct 15, 2025.
The company will issue LIFE-eligible flow-through shares and a Concurrent Private Placement of 5,230,200 common shares at C$4.78 per share for gross proceeds of C$25,000,356 (Concurrent Private Placement size increased by about C$15 million).
Closing is expected on or about Oct 29, 2025, subject to regulatory approvals including TSXV and NYSE approvals; shares from the Concurrent Private Placement will have a four months plus one day statutory hold.
Osisko Development (NYSE: ODV) ha ulteriormente aumentato il finanziamento tramite offerta acquistata annunciato in precedenza, portandolo a un totale di 75 milioni di CAD nell’offerta del 15 ottobre 2025.
L’azienda emetterà azioni flow-through idonee LIFE e un Collocamento Privato Concomitante di 5.230.200 azioni ordinarie a 4,78 CAD per ricavi lordi di 25.000.356 CAD (la dimensione del Collocamento Privato Concomitante è aumentata di circa 15 milioni di CAD).
La chiusura è prevista verso il 29 ottobre 2025, soggetta ad approvazioni regolamentari tra cui le approvazioni TSXV e NYSE; le azioni del Collocamento Privato Concomitante avranno una sospensione statutaria di quattro mesi più un giorno.
Osisko Development (NYSE: ODV) ha aumentado aún más su financiación mediante la oferta de compra anunciada previamente, a un total de 75 millones de CAD en la oferta del 15 de octubre de 2025.
La empresa emitirá acciones flow-through elegibles LIFE y un Colocación Privada Concurrente de 5,230,200 acciones ordinarias a 4,78 CAD por ingresos brutos de 25,000,356 CAD (el tamaño de la Colocación Privada Concurrente se incrementó en aproximadamente 15 millones de CAD).
Se espera el cierre para el 29 de octubre de 2025, sujeto a aprobaciones regulatorias, incluidas las aprobaciones de TSXV y NYSE; las acciones de la Colocación Privada Concurrente tendrán una retención estadutaria de cuatro meses más un día.
Osisko Development (NYSE: ODV)가 이전에 발표된 매수형 공모 자금 조달을 추가로 확대하여 2025년 10월 15일 총 7,500만 CAD의 오퍼링으로 이루어집니다.
회사는 LIFE 적합 플로우스루 주를 발행하고 4.78 CAD의 주당 가격으로 5,230,200주를 동시 비공개 배정하는 동시 비공개 배정(CPP)을 통해 매출 2,5000,356 CAD를 확보합니다(CPP 규모는 약 1,5000만 CAD 증가).
마감은 2025년 10월 29일경으로 예상되며, TSXV 및 NYSE 승인을 포함한 규제 승인에 따라 달라질 수 있습니다. CPP의 주식은 4개월+1일의 법적 보유기간이 적용됩니다.
Osisko Development (NYSE: ODV) a encore augmenté son financement par achat-vente annoncé précédemment, pour atteindre une offre totale de 75 millions de CAD le 15 octobre 2025.
L’entreprise émettra des actions flow-through éligibles LIFE et une Placement Privé Concurrent de 5 230 200 actions ordinaires à 4,78 CAD par un produit brut de 25 000 356 CAD (la taille du Placement Privé Concurrent a été portée d’environ 15 millions de CAD).
La clôture est prévue vers le 29 octobre 2025, sous réserve des approbations réglementaires, y compris les approbations de la TSXV et de la NYSE ; les actions du Placement Privé Concurrent auront une période de blocage statutaire de quatre mois et un jour.
Osisko Development (NYSE: ODV) hat seine zuvor angekündigte Finanzierung durch Bought-Deal weiter aufgestockt auf ein Gesamtvolumen von 75 Millionen CAD bei der Offerte vom 15. Oktober 2025.
Das Unternehmen wird LIFE-berechtigte Flow-Through-Aktien ausgeben und eine Concurrently Private Placement von 5.230.200 Stammaktien zu 4,78 CAD pro Aktie für Bruttoerlöse von 25.000.356 CAD durchführen (Größe des Concurrent Private Placement um etwa 15 Millionen CAD erhöht).
Der Abschluss wird voraussichtlich am 29. Oktober 2025 erfolgen, vorbehaltlich regulatorischer Genehmigungen einschließlich der Genehmigungen der TSXV und NYSE; Aktien des Concurrent Private Placement unterliegen einer gesetzlich festgelegten Sperrfrist von vier Monaten und einem Tag.
Osisko Development (NYSE: ODV) زاد من تمويله عبر الصفقة الشرائية المعلنة سابقاً ليصل إلى إجمالي 75 مليون دولار كندي في العرض المؤرخ 15 أكتوبر 2025.
ستصدر الشركة أسهماً من فئة FLOW-THROUGH المؤهَّلة LIFE، وعملية طرح خاص متزامن لـ 5,230,200 سهم عادي بسعر 4.78 دولار كندي للسهم لإيرادات إجمالية قدرها 25,000,356 دولار كندي (تم زيادة حجم الطرح الخاص المتزامن بحوالي 15 مليون دولار كندي).
من المتوقع الإغلاق في تقريباً 29 أكتوبر 2025، رهناً بالموافقات التنظيمية بما فيها موافقات TSXV وNYSE؛ ستخضع الأسهم من الطرح الخاص المتزامن لقيد حظر امتداده أربعة أشهرplus يوم واحد.
Osisko Development (NYSE: ODV) 进一步将其先前宣布的买入交易融资扩大为
公司将发行 LIFE 合格的 FLOW-THROUGH 股票,并以每股 4.78 加元的价格进行 并行私募配售 5,230,200 股普通股,毛额募集 25,000,356 加元(并行私募配售规模增加约 1500 万加元)。
预计于 2025 年 10 月 29 日 左右完成,须经监管批准包括 TSXV 与 NYSE 的批准;并行私募配售的股票将有 四个月加一天 的法定禁售期。
- Total financing increased to C$75 million
- Concurrent Private Placement raised C$25,000,356
- Concurrent placement priced at C$4.78 per share
- Issuance of 5,230,200 common shares increases outstanding share count
- Closing is conditional on TSXV and NYSE approvals
- Concurrent shares subject to four months and one day hold
Insights
Upsize reflects clear excess demand; increases immediate capital raised and widens investor base.
By increasing the Concurrent Private Placement from
The transaction depends on regulatory approvals including the conditional approval of the TSX Venture Exchange and the New York Stock Exchange; failure to obtain these would halt the deal. Closing is expected on or about
Upsize signals buyer appetite and increases gross proceeds to
The structure preserves the previously announced mix of LIFE-exempt flow-through tranches (~
Key near-term items to watch are receipt of all regulatory approvals and the four-month-and-one-day statutory hold period on the concurrently placed Common Shares; expect clarity by
Total Upsized Offering of C
MONTREAL, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce that, as a result of excess demand, it has entered into a further amending agreement (the "Amendment") with the underwriters to increase the size of its previously announced "bought deal" financing from C
As announced by the Company on October 9, 2025 (see news release entitled "Osisko Development Announces Upsizing of Previously Announced "Bought Deal" LIFE Offering; Additional Concurrent Private Placement"), Osisko Development has agreed to issue (i) three tranches of shares under the "listed issuer financing exemption" available under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "LIFE Exemption") in each of the provinces and territories of Canada, comprising national flow-through shares, British Columbia flow-through shares and common shares of the Company ("Common Shares"), for gross proceeds of approximately C
Pursuant to the Amendment, the Company has agreed to increase the size of the Concurrent Private Placement by approximately C
Closing of the LIFE Offering and the Concurrent Private Placement are expected to occur on the same date, being on or about October 29, 2025 (the "Closing Date"), and remain subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the conditional approval of the TSX Venture Exchange and the approval of the New York Stock Exchange. The Common Shares issued under the Concurrent Private Placement will be subject to a statutory hold period of four months and one day pursuant to applicable Canadian securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. state securities laws, and may not be offered or sold in the United States absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom.
ABOUT OSISKO DEVELOPMENT CORP.
Osisko Development Corp. is a continental North American gold development company focused on past-producing mining camps located in mining friendly jurisdictions with district scale potential. The Company's objective is to become an intermediate gold producer by advancing its flagship permitted
For further information, visit our website at www.osiskodev.com or contact:
Sean Roosen | Philip Rabenok |
Chairman and CEO | Vice President, Investor Relations |
Email: sroosen@osiskodev.com | Email: prabenok@osiskodev.com |
Tel: +1 (514) 940-0685 | Tel: +1 (437) 423-3644 |
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward- looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee" or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements in this news release may include, without limitation, statements pertaining to: the size of the Offering and the Concurrent Private Placement, the use of the net proceeds from the Offering and the Concurrent Private Placement, the closing of the Offering and the Concurrent Private Placement, the tax treatment of the Flow-Through Shares, the timing and ability of the Company to renounce the Qualifying Expenditures and the ability to obtain the necessary regulatory authority approvals. Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Actual results could differ materially due to a number of factors, including, without limitation, marketing of the Offering and the Concurrent Private Placement, and satisfying the conditions of closing of the Offering and the Concurrent Private Placement, including the requirements of the New York Stock Exchange and the TSX Venture Exchange (if at all). Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
